Jane Street’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.5M | Sell |
167,800
-290,200
| -63% | -$20.2M | ﹤0.01% | 2472 |
|
|
2025
Q4 | $30.4M | Sell |
458,000
-200
| -0% | -$12.9K | ﹤0.01% | 1253 |
|
|
2025
Q3 | $30.8M | Buy |
458,200
+157,500
| +52% | +$12.5M | ﹤0.01% | 1273 |
|
|
2025
Q2 | $26.2M | Sell |
300,700
-38,400
| -11% | -$3.01M | 0.01% | 1203 |
|
|
2025
Q1 | $23.2M | Sell |
339,100
-206,400
| -38% | -$16.8M | 0.01% | 1188 |
|
|
2024
Q4 | $42.4M | Buy |
545,500
+157,000
| +40% | +$11.6M | 0.01% | 777 |
|
|
2024
Q3 | $26M | Buy |
388,500
+286,400
| +281% | +$23.5M | 0.01% | 1056 |
|
|
2024
Q2 | $11.6M | Sell |
102,100
-107,800
| -51% | -$13.6M | ﹤0.01% | 1865 |
|
|
2024
Q1 | $29.1M | Sell |
209,900
-97,700
| -32% | -$12.3M | 0.01% | 935 |
|
|
2023
Q4 | $38.2M | Buy |
307,600
+69,600
| +29% | +$7.11M | 0.01% | 819 |
|
|
2023
Q3 | $22.2M | Buy |
238,000
+44,200
| +23% | +$4.98M | 0.01% | 1020 |
|
|
2023
Q2 | $24.9M | Sell |
193,800
-62,200
| -24% | -$7.52M | 0.01% | 1020 |
|
|
2023
Q1 | $29.7M | Sell |
256,000
-86,900
| -25% | -$9.73M | 0.01% | 761 |
|
|
2022
Q4 | $38.8M | Buy |
342,900
+144,100
| +72% | +$15.8M | 0.02% | 643 |
|
|
2022
Q3 | $16M | Sell |
198,800
-38,000
| -16% | -$3.22M | 0.01% | 1260 |
|
|
2022
Q2 | $17.6M | Sell |
236,800
-27,200
| -10% | -$2.48M | 0.01% | 1217 |
|
|
2022
Q1 | $33.8M | Sell |
264,000
-282,800
| -52% | -$30.9M | 0.01% | 904 |
|
|
2021
Q4 | $73.4M | Sell |
546,800
-96,000
| -15% | -$13.8M | 0.02% | 485 |
|
|
2021
Q3 | $87.9M | Buy |
642,800
+46,000
| +8% | +$5.8M | 0.03% | 381 |
|
|
2021
Q2 | $63.7M | Buy |
596,800
+379,200
| +174% | +$36.4M | 0.02% | 451 |
|
|
2021
Q1 | $19.6M | Sell |
217,600
-95,600
| -31% | -$8.97M | 0.01% | 991 |
|
|
2020
Q4 | $28.9M | Sell |
313,200
-94,800
| -23% | -$8.46M | 0.01% | 669 |
|
|
2020
Q3 | $42M | Sell |
408,000
-518,000
| -56% | -$54.1M | 0.03% | 457 |
|
|
2020
Q2 | $93.8M | Buy |
926,000
+774,800
| +512% | +$69.3M | 0.07% | 196 |
|
|
2020
Q1 | $10.2M | Buy |
151,200
+87,200
| +136% | +$5.43M | 0.01% | 761 |
|
|
2019
Q4 | $3.5M | Sell |
64,000
-2,400
| -4% | -$114K | ﹤0.01% | 1372 |
|
|
2019
Q3 | $2.48M | Buy |
66,400
+25,200
| +61% | +$979K | ﹤0.01% | 1580 |
|
|
2019
Q2 | $1.54M | Sell |
41,200
-159,600
| -79% | -$5.02M | ﹤0.01% | 2169 |
|
|
2019
Q1 | $5.98M | Buy |
200,800
+177,600
| +766% | +$6.24M | 0.01% | 1009 |
|
|
2018
Q4 | $695K | Sell |
23,200
-17,600
| -43% | -$558K | ﹤0.01% | 3049 |
|
|
2018
Q3 | $1.46M | Buy |
+40,800
| New | +$1.26M | ﹤0.01% | 2276 |
|
|
2018
Q2 | – | Sell |
-56,400
| Closed | -$1.05M | – | 5074 |
|
|
2018
Q1 | $1.05M | Buy |
+56,400
| New | +$834K | ﹤0.01% | 2602 |
|
|
2017
Q2 | – | Sell |
-12,000
| Closed | -$254K | – | 4429 |
|
|
2017
Q1 | $254K | Buy |
+12,000
| New | +$234K | ﹤0.01% | 3618 |
|
|
2016
Q4 | – | Sell |
-43,200
| Closed | -$947K | – | 4110 |
|
|
2016
Q3 | $947K | Buy |
+43,200
| New | +$962K | ﹤0.01% | 2042 |
|
|
2016
Q2 | – | Sell |
-31,200
| Closed | -$530K | – | 4164 |
|
|
2016
Q1 | $530K | Buy |
+31,200
| New | +$521K | ﹤0.01% | 2536 |
|
|
2015
Q4 | – | Sell |
-28,800
| Closed | -$618K | – | 4075 |
|
|
2015
Q3 | $618K | Buy |
+28,800
| New | +$643K | ﹤0.01% | 2091 |
|
Other funds holding DXCM
VCM
VPM
Jane Street's DXCM Position: Q1 2026 in Review
Jane Street increased its DexCom (DXCM) stake by 1,363% in Q1 2026, buying an estimated $48.1M and bringing the position to 741,669 shares worth $46.6M. The position accounts for 0.01% of the portfolio, ranked #1110.
Jane Street first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $129M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Jane Street held 741,669 shares of DexCom worth $46.6M as of Q1 2026.
- Jane Street bought 690,966 DexCom shares in Q1 2026, an estimated $48.1M.
- DexCom made up 0.01% of Jane Street's portfolio in Q1 2026, its #1110 holding.
- Jane Street first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
- Jane Street's DexCom position peaked at $129M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.